Korean biotechnology company RNL Bio has opened its European operation at Newcastle University to develop its stem cell research programme.
RNL Bio specialises in stem cell research and develops therapeutic products and regenerative medicine. The firm currently employs around 85 members of staff and has been brought to the north east following a joint venture between One NorthEast, the North East Stem England Cell Institute (NESCI) and life science centre Cels.
The firm will use its Newcastle base to develop stem cell therapy products for diseases by isolating and culturing stem cells derived from a range of sources. It is also funding research projects in NESCI laboratories.